Literature DB >> 12683553

Multi-photon microscopic evaluation of saphenous vein endothelium and its preservation with a new solution, GALA.

Hemant S Thatte1, Kunda S Biswas, Samer F Najjar, Vladimir Birjiniuk, Michael D Crittenden, Thomas Michel, Shukri F Khuri.   

Abstract

BACKGROUND: Injury to endothelium can compromise the patency of bypass grafts harvested during coronary artery bypass graft (CABG) surgery. Maintaining structural and functional viability of endothelium in grafts may lead to improved long-term patency. The information gained from the application of multi-photon microscopy in transmission and epifluorescence mode was used to assess the structural and functional integrity of human saphenous vein segments stored in multiple preservation solutions, and to design a superior storage solution.
METHODS: Multi-photon microscopy was used to image deep within saphenous vein tissue harvested from patients undergoing CABG for analysis of endothelial structure and function. Endothelial cell structural viability, calcium mobilization, and nitric oxide generation were determined using specific fluorescence markers.
RESULTS: Within 60 minutes of harvest and storage in standard preservation solutions, calcium mobilization and nitric oxide generation were markedly diminished with more than 90% of endothelial cells no longer viable in the vein. In contrast, veins could be stored for 24 hours without substantial loss in cell viability in a newly formulated heparinized physiologic buffered salt solution containing glutathione, ascorbic acid, and L-arginine (GALA).
CONCLUSIONS: Standard solutions in clinical use today led to a profound decline in saphenous vein endothelial cell viability, whereas the newly designed physiologic salt solution (GALA) maintained endothelial function and structural viability for up to 24 hours. The improvements seen from using GALA as a vessel storage medium may lead to greater long-term vein graft patency following CABG surgery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12683553     DOI: 10.1016/s0003-4975(02)04705-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

1.  Preservation solution impacts physiologic function and cellular viability of human saphenous vein graft.

Authors:  Eric S Wise; Kyle M Hocking; Susan Eagle; Tarek Absi; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  Surgery       Date:  2015-05-21       Impact factor: 3.982

2.  DuraGraft vascular conduit preservation solution in patients undergoing coronary artery bypass grafting: rationale and design of a within-patient randomised multicentre trial.

Authors:  Walid Ben Ali; Pierre Voisine; Peter Skov Olsen; Hugues Jeanmart; Nicolas Noiseux; Tracy Goeken; Vilas Satishchandran; Filippo Cademartiri; Garry Cutter; Dave Veerasingam; Craig Brown; Maximilian Y Emmert; Louis P Perrault
Journal:  Open Heart       Date:  2018-04-13

3.  Development and Preliminary Testing of Porcine Blood-Derived Endothelial-like Cells for Vascular Tissue Engineering Applications: Protocol Optimisation and Seeding of Decellularised Human Saphenous Veins.

Authors:  Andrew Bond; Vito Bruno; Jason Johnson; Sarah George; Raimondo Ascione
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

4.  Effect of Troglitazone on expression of adhesion molecules and eNOS in human saphenous vein graft.

Authors:  Shu Chen; Zhiwei Hu; Kailun Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-12

5.  Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial.

Authors:  Ralf E Harskamp; John H Alexander; Phillip J Schulte; Colleen M Brophy; Michael J Mack; Eric D Peterson; Judson B Williams; C Michael Gibson; Robert M Califf; Nicholas T Kouchoukos; Robert A Harrington; T Bruce Ferguson; Renato D Lopes
Journal:  JAMA Surg       Date:  2014-08       Impact factor: 14.766

Review 6.  Saphenous vein grafts in contemporary coronary artery bypass graft surgery.

Authors:  Etem Caliskan; Domingos Ramos de Souza; Andreas Böning; Oliver J Liakopoulos; Yeong-Hoon Choi; John Pepper; C Michael Gibson; Louis P Perrault; Randall K Wolf; Ki-Bong Kim; Maximilian Y Emmert
Journal:  Nat Rev Cardiol       Date:  2019-08-27       Impact factor: 32.419

7.  Antegrade cardioplegia as a possible cause of acute saphenous vein endothelial damage in patients undergoing on pump coronary artery bypass surgery.

Authors:  Ioannis Koukis; Stavros Siminelakis; Michalis Argiriou; Nikolaos Theakos; Anna Takou; George Pounis; Christos Charitos; Efstratios Apostolakis
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

8.  Evaluation of endoscopic vein extraction on structural and functional viability of saphenous vein endothelium.

Authors:  Bader E Hussaini; Xiu-Gui Lu; J Alan Wolfe; Hemant S Thatte
Journal:  J Cardiothorac Surg       Date:  2011-06-10       Impact factor: 1.637

9.  Imaging of nitric oxide in nitrergic neuromuscular neurotransmission in the gut.

Authors:  Hemant S Thatte; Xue D He; Raj K Goyal
Journal:  PLoS One       Date:  2009-04-02       Impact factor: 3.240

10.  Influence of ischemia before vein grafting on early hyperplasia of the graft and the dynamic changes of the intima after grafting.

Authors:  Rongjiang Zou; Mingjuan Sun; ZhiQian Lu; Qingkui Guo
Journal:  J Cardiothorac Surg       Date:  2012-09-24       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.